Skip to main content
Immunity, Inflammation and Disease logoLink to Immunity, Inflammation and Disease
. 2021 Jun 2;9(3):1009–1015. doi: 10.1002/iid3.464

Time‐related variation in IgG subclass concentrations in a group of healthy Danish adults

Kristina Fruerlund Rasmussen 1,, Ulrik Sprogøe 1, Christian Nielsen 1, Dana‐Bar Shalom 1,2, Kristian Assing 1
PMCID: PMC8342227  PMID: 34080322

Abstract

Introduction

Immunoglobulin G subclass measurements are important for the diagnostic work‐up of immunodeficiencies and immunoglobulin G4 (IgG4) related diseases. It is currently unknown whether a single sampling is truly representative for an individual's IgG subclass concentrations. This study aimed to investigate whether IgG and IgG subclass concentrations in healthy individuals are stable over time.

Method

With a span of median 42 weeks, four samples from each of 54 (34M, 20F) healthy adult volunteers (24–66 years) were analyzed for IgG and IgG1–4 using turbidimetry. Concentrations were compared within and between individuals.

Results

IgG and IgG subclass concentrations followed either a normal (IgG, IgG1, and IgG3) or log normal (IgG2 and IgG4) distribution. Immunoglobulin 4 demonstrated by far the widest range of concentrations between individuals (670‐fold: 0.004–2.68 g/L). Immunoglobulin G subclass variations within individuals were expressed as pooled standard deviations (PSD). These ranged from 0.056 (IgG4) to 0.955 g/L (IgG) and correlated with mean concentration of IgG or the particular IgG subclass. As a consequence, the relative PSDs (i.e., PSD divided by mean IgG or IgG subclass concentration) fell within a narrow range: 5.82%–10.1%. Based on these numbers, the 95%‐upper one‐sided confidence limits for intraindividual IgG and IgG subclass variation was calculated to range from 9.82% (IgG2) to 16.9% (IgG4).

Conclusion

The study documents that IgG or IgG subclass concentrations within healthy individuals are very stable over at least 42 weeks. The expected variation for IgG4 concentrations at a 95% confidence level does not exceed ±16.9%.

Keywords: adult, immunoglobulin G, immunoglobulin G4‐related disease, observational study


Abbreviations

CI

confidence interval

IgG

immunoglobulin

PSD

pooled standard deviations

SD

standard deviation

1. INTRODUCTION

Serum concentrations of immunoglobulin G (IgG) subclasses have been associated with various disorders and diseases. Low amounts of IgG subclass antibodies are associated with humoral immunodeficiency1, 2, 3, 4, 5, 6 while high amount of IgG subclass antibodies, especially IgG4, have been associated with systemic diseases, such as storiform fibrosis and obliterative phlebitis.7, 8, 9 Therefore, assessment of IgG1‐4 subclass concentrations is part of the diagnostic work‐up in rheumatological, gastrointestinal and neurological diseases or in the clinical evaluation of patients with primary or secondary immune deficiencies.1, 10, 11, 12, 13 More specifically, in the case of IgG4 related diseases, measurement of an individual's IgG4 concentration is used as a diagnostic guide. 14 Determining IgG subclass concentrations is of expanding clinical relevance due to accumulating evidence of IgG subclass related diseases.15, 16, 17 Hence, it is of clinical relevance to establish variation in IgG subclass concentrations over time to determine how representative a single IgG subclass determination is. To the best of the authors' knowledge, intraindividual variation of serum IgG subclass concentrations has not previously been described. Further, only a few cross‐sectional studies on IgG subclass reference intervals in healthy individuals have been published.18, 19, 20, 21

It has previously been established that serum IgG antibodies are stable in frozen and thawed samples.9, 22, 23 Thus, it is possible to use previously collected and frozen samples for the purpose of estimating intraindividual variations of IgG subclass levels over a period of time covered by the collected samples.

The aim of this study is to investigate the biological intra‐ and interindividual variations in immunoglobulin IgG subclass concentrations—with particular focus on IgG4—in an array of frozen samples collected serially from a group of healthy adults.

2. MATERIALS AND METHODS

2.1. Study design

This study was part of a previously published prospective study which described intraindividual variation of anti‐A and/or anti‐B titers. 23

Serum and plasma samples were collected from a cohort of 59 healthy volunteers consisting of blood donors or employees at the Department of Clinical Immunology, Odense University Hospital. Participants were more than 18 years old and Caucasians. Volunteers had given written informed consent to the use of the samples for research purposes. Exclusion criteria were those pertaining to Danish blood donors: presence of symptomatic autoimmune disease, type 1 diabetes, malignancy (previous/current), viral or parasitic disease with blood transmission, symptomatic infection, pregnancy, use of oral or injected medicine within two weeks before sampling or ongoing use of these medications. 24 Volunteers were not financially compensated.

2.2. Blood sampling

A total of four serum and plasma samples from each volunteer were collected at approximately every third month covering a period of approximately ten months from May 2012 to August 2013. Sampling time of the day varied randomly. The samples were collected by venipuncture and fractionated serum and plasma was frozen in aliquots at −80°C within one hour after sampling.

2.3. IgG subclass analysis

Aliquots were thawed and IgG and IgG1, IgG2, IgG3, and IgG4 subclass concentrations were analyzed with turbidimetry using commercially available kits (Product Code NK004.S., NK006.S., NK007.S., LK008.S., LK009.S, The Binding Site) and a SPAPLUS analyzer (The Binding Site) in accordance with the manufacturer's instructions. 21 The assay was validated for use on either plasma or serum samples. According to the manufacturer, the analytical range for the IgG4 assay is 0.003–3.4 g/L.25, 26

2.4. Data analysis

Basic data analysis was carried out using Microsoft Excel 2010 (Microsoft) by calculating mean individual IgG and IgG subclass concentrations, 95%‐distribution limits of interindividual mean IgG and IgG subclass concentrations and pooled standard deviations (SD) and 95%‐upper distribution limits of intraindividual IgG and IgG subclass variations. The pooled SD was calculated as:

Squareroot((varianceacrossfourmeasurementsinanindividual)/n);n=numberofindividuals

Pooled relative SD for intraindividual subclass variation was calculated as:

Squareroot((variance/mean×2acrossfourmeasurementsinanindividual)/n);n=numberofindividuals

Confidence limits were calculated as:

SD×t0.05atn1degreesoffreedom;n=numberofindividuals(Forn=54,t0.05atn1degreesoffreedom=1.675)

For one‐sided confidence limits, t 0.05 of one‐sided t distribution was used. Further statistical analysis and graphics was performed using GraphPad Prism 7 (GraphPad Software) or JMP 12.01 (SAS Institute Inc.). Evaluation of adherence to normal distribution of mean individual IgG or IgG subclass level between individuals was performed using Shapiro‐Wilks W test in JMP.

To distribute the number of individuals in age groups of fairly equal size, age intervals were set at 24–44 years, 45–54, 55–62, and 63–66 years. Test of differences of mean IgG and IgG subclass concentrations across these age groups was performed using analysis of variance.

Unless otherwise stated, the level of statistical significance was set at two‐tailed distribution p < .05 for all statistical tests.

3. RESULTS

3.1. Study population

Of the 59 eligible volunteers, 54 included participants completed the study. One female withdrew her consent. One male was excluded due to health issues and further three males were excluded as they failed to donate four samples. The characteristics of the participants are presented in Table 1. There was no difference in mean age between females and males (53.5 vs. 51.4 years respectively, p = .63). Median duration between sample collections was 14 weeks (range 7–29 weeks).

Table 1.

Population characteristics (N = 54)

Sex Age (years) Observation period (weeks)
Male 34 (63%) 54 (24–66) 42 (37–52)
Female 20 (37%)

Note: Age and observation period are given as median (range).

Immunoglobulin G, IgG1 and IgG3 concentrations were normally distributed (Shapiro–Wilks p ≥ .48) between individuals and IgG2 and IgG4 concentrations were log normally distributed (Shapiro–Wilks p = .097 and p = .50, respectively). Regarding IgG4, adhering to the log normal distribution required removal of an outlier representing the lowest IgG4 concentration measured, 0.004 g/L (all IgG4 data: Shapiro–Wilks p = .01). See Figure 1 for examples.

Figure 1.

Figure 1

Typical distributions of IgG and IgG subclass concentrations across individuals. Normal quantile plots (top) and histograms (bottom) with fitted normal distribution (red curve) showing typical distributions of IgG and IgG4 subclass concentrations across individuals. Immunoglobulin G concentrations (Panel 1) conform to a normal distribution. For IgG4, concentrations (Panel 2 and 3) adhere to log normal distribution after removal of one outlier (Panel 3). N = 54 (each dot represents the mean of four measurements from an individual). IgG, immunoglobulin G

Subject to availability of serum samples, 15 out of the total 216 (6.9%) samples were EDTA‐plasma. The few plasma samples were randomly distributed across participants, with one sample from each of 11/54 (20%) participants and two samples from each of 2/54 (3.7%) participants.

The basic data on IgG and IgG1‐4 distributions across individuals (interindividual variation) are presented in Table 2. All 1080 IgG and IgG1‐4 measurements fell within the manufacturer's declared analytical ranges of the IgG and IgG‐subclass assays.

Table 2.

Descriptive statistics for IgG and IgG subclass concentrations (g/L) (N = 54)

IgG type Mean (SD) 95% CI Median Percentiles (2.5%–97.5%) Range (g/L)
IgG 11.4 (1.98) 7.43–15.4 11.6 7.49–16.0 7.22–16.7
IgG1 6.46 (1.46) 3.52–9.40 6.44 3.79–9.98 3.76–10.6
IgG2 3.75 (1.01) 2.10–6.22a 3.43 1.97–5.73 1.83–5.85
IgG3 0.69 (0.28) 0.12–1.25 0.67 0.18–1.39 0.15–1.48
IgG4 0.45 (0.47) 0.03–2.67a 0.33 0.02–2.34 0.004–2.68

Abbreviations: CI, confidence interval; IgG, immunoglobulin G.

a

Estimate based on a logarithmic distribution model.

3.2. Intraindividual and interindividual variation

The range of IgG4 concentrations across individuals relative to those of IgG1–3 was wide (0.004–2.680 g/L). The interindividual variability of IgG4 concentrations is underscored by (Table 2) a higher ratio between IgG4 mean and IgG4 median (1.36) compared to 0.98–1.09 for IgG and IgG1–3. Data on the intraindividual variation of IgG and IgG1‐4 concentrations across four measurements (Table 3) are expressed as pooled SD (SD relating to variation over time, then pooled across participants). It is apparent that the pooled SD correlates to mean immunoglobulin concentration (Tables 2 and 3), indicating that variation over time for IgG or an IgG subclass is decreasing proportionally with mean concentration of that particular immunoglobulin. Pooled relative SD, calculated by taking into account this relationship (dividing pooled SD with mean of relevant IgG and IgG subclass concentrations) revealed that the differences between IgG and between the four subclasses in relative variation over time were rather small with a maximum 1.7 fold difference between the lowest (5,85%, IgG2) and the highest (10.1%, IgG4) relative SD. The maximum 95% relative upper CI (Table 3) of 16.9% (IgG4) indicates that IgG and IgG subclass concentrations of an individual are very stable across time

Table 3.

Intraindividual variation in IgG and IgG subclasses across four measurements

Ig type Pooled SD (g/L) 95% Upper CI (g/L) Pooled rel. SD (%) a 95% Rel. upper CI (%) a
IgG 0.955 1.600 8.92 14.9
IgG1 0.536 0.898 8.39 14.1
IgG2 0.222 0.372 5.86 9.82
IgG3 0.058 0.097 8.40 14.1
IgG4 0.056 0.093 10.1 16.9

Note: With IgG1 as an example the CIs in the table may be read as: Maximum time related intraindividual variation of IgG1 at 95% probability = ±0.898 g/L. At a mean level of IgG1 of 6.46 g/L (Table 2) this corresponds to an approximate interval of IgG1 of 5.6–7.4 g/L. Alternatively, expressed relatively: IgG1 level ±14.1%, which corresponds to an approximate interval of IgG1 of 86%–114%.

Abbreviations: CI, confidence interval; IgG, immunoglobulin G.

a

Estimates of relative SD and 95% upper CI on relative variation.

For IgG4, this is further illustrated in Figure 2. Here, all IgG4 concentrations are visualized with each participant's four measurements represented by a dotted line. Only for a few subjects, there was a significant fluctuation of IgG4 level across time.

Figure 2.

Figure 2

IgG4 variation over time. Time‐related variation of IgG4 concentration in 54 individuals across four measurements. Note different concentrations of Y‐axis. IgG, immunoglobulin G

3.3. Variation in immunoglobulin level in relation to sex and age

No statistically significant differences in mean IgG or mean IgG1–4 subclass concentrations according to sex were identified (Student's T test, .10 < p < .68, data not shown). The four defined age groups (24–44, 45–54, 55–62, and 63–66 years) were comprised of 11 to 15 persons. There was no statistically significant association between mean IgG or IgG1–4 subclass concentrations and age group (.10 < p < .33, data not shown).

4. DISCUSSION

The main novel finding of the study is with regard to the intraindividual variations in concentrations of IgG and IgG1–4 subclasses by repeated sampling over a time span of 10 months. Overall, variations between repeated measurements were small. According to the data on pooled standard deviations, intraindividual variation range from 0.056 g/L for IgG4 to 0.955 g/L for total IgG. Interestingly, the pooled SD pertaining to an IgG subclass was proportional to the mean concentration level of the particular subclass. This allowed for the calculation of pooled relative standard deviations as a measure of the time‐related variations of the IgG subclasses relative to the subclass concentrations. Further calculation yielded one‐sided 95%‐CIs on the relative variations. The highest, 16.9% was seen for IgG4, but they were fairly consistent across subclasses and total IgG with no clear increasing or decreasing tendency relative to mean immunoglobulin level (Table 3). The main implication of these findings is that regardless of IgG subclass, intraindividual time‐related variation do not exceed 17%, meaning that any single measurement of IgG or IgG1–4 subclass with a 95% certainty will lie within an 83%–117% range of the “true” value of the measured total IgG or IgG subclass for that particular individual.

Compared to the concentration of total IgG and each of the other three IgG subclasses, interindividual IgG4 concentrations spanned the widest range of values. In fact, three participants demonstrated mean IgG4 values above 1.35 g/L (male 65 years, male 36 years and female 47 years), which is normally considered the upper normal limit, when considering IgG4 related disease.7, 27 As the study participants all entered the study as healthy individuals without signs of chronic disease, there is no indication that these three individuals may have had IgG4 related disease. At the other end of the IgG4 spectrum, four of 54 participants presented with mean IgG4 values less than 0.05 g/L. However, as shown by Figure 2 regardless of the mean IgG4 level of an individual the intraindividual IgG4 variation was at a most modest level. The wide range of IgG4 concentrations must therefore be assumed to be an indication of the true biological variation of IgG4 rather than caused by measurement errors.

This wide interindividual IgG4 range is consistent with previous studies on the interindividual variation in other human biological markers, for example, lymphocyte subsets.28, 29, 30 Similarly, small intraindividual variation has also been demonstrated in other studies, for example, cytokines or lymphocytes. 30

There are limitations to this study. The main being that it includes a relatively small number of participants and that the age span of the participants was limited to 24–66 years. It is clear, that a larger study population with inclusion of older and younger participants would have yielded results that are more generalizable. The fact that the participants were all healthy adults further makes it difficult to draw a direct comparison of results the study to various patient groups. Although the wide range of concentration of IgG4 gives confidence on what variations to expect in patient groups with IgG4 related disease.

An additional caveat is that the study was confined to four measurements per subject with a median distance of 14 weeks between samplings. As such, it cannot be ruled out that larger IgG level variations than those presented here, may be the case when samplings are years or further apart. On the other hand, since the time interval between samplings from the individual participants carried some random variation, it is far less likely that short term IgG variations are present, but not detected by this study. We conclude that the data presented in this study demonstrates a high degree of stability in IgG subclass concentrations within adult healthy Danish adults over time. This knowledge is applicable in the clinic for investigating patients for IgG subclass related disease.

CONFLICT OF INTERESTS

The authors declare that there are no conflict of interests.

AUTHOR CONTRIBUTIONS

Kristina Fruerlund Rasmussen has contributed to the conception and design of work. She has analysed the data. She has drafted the work and approved the final version of the article. Ulrik Sprogøe carried out data analysis and statistical testing. Further, he cowrote and edited the manuscript. Christian Nielsen has been involved in laboratory work analyzing the data. He has drafted the work and approved the final version of the article. Dana Bar Shalom has contributed to laboratory work, co‐edited and approved the final version of the article. Kristian Assing has collected data and consents. He has contributed to the conception and design of work. He supervised the work. He has drafted the work and approved the final version of the article.

ETHICS STATEMENT

All participants had given written and informed consent before entry into the study. The research protocol was reviewed and approved by the Regional Committees on Health Research Ethics for Southern Denmark (Protocol‐identification: S‐20110085).

ACKNOWLEDGMENTS

The authors would like to thank Mads Hvidkjær Rasmussen for practical support in handling samples. AH Diagnostics A/S provided the Binding Site diagnostic kits used in the project.

Rasmussen KF, Sprogøe U, Nielsen C, Shalom D, Assing K. Time‐related variation in IgG subclass concentrations in a group of healthy Danish adults. Immun Inflamm Dis. 2021;9:1009‐1015. 10.1002/iid3.464

Kristina Fruerlund Rasmussen and Ulrik Sprogøe contributed equally to this study.

DATA AVAILABILITY STATEMENT

The data that support the findings of this study are available on request from the corresponding author. The data are not publicly available due to privacy or ethical restrictions.

REFERENCES

  • 1. Parker AR, Skold M, Ramsden DB, Ocejo‐Vinyals JG, Lopez‐Hoyos M, Harding S. The clinical utility of measuring IgG subclass immunoglobulins during immunological investigation for suspected primary antibody deficiencies. Lab Med. 2017;48(4):314‐325. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2. Soderstrom T, Soderstrom R, Avanzini A, Brandtzaeg P, Karlsson G, Hanson LA. Immunoglobulin G subclass deficiencies. Int Arch Allergy Appl Immunol. 1987;82(3‐4):476‐480. [DOI] [PubMed] [Google Scholar]
  • 3. Schatorje EJ, de Jong E, van Hout RW, Garcia Vivas Y, de Vries E. The challenge of immunoglobulin‐G subclass deficiency and specific polysaccharide antibody deficiency—a Dutch pediatric cohort study. J Clin Immunol. 2016;36(2):141‐148. [DOI] [PubMed] [Google Scholar]
  • 4. Odat H, Alqudah M. Prevalence and pattern of humoral immunodeficiency in chronic refractory sinusitis. Eur Arch Oto‐Rhino‐Laryngol. 2016;273(10):3189‐3193. [DOI] [PubMed] [Google Scholar]
  • 5. May A, Zielen S, von Ilberg C, Weber A. Immunoglobulin deficiency and determination of pneumococcal antibody titers in patients with therapy‐refractory recurrent rhinosinusitis. Eur Arch of Oto‐Rhino‐laryngol. 1999;256(9):445‐449. [DOI] [PubMed] [Google Scholar]
  • 6. De Gracia J, Rodrigo MJ, Morell F, et al. IgG subclass deficiencies associated with bronchiectasis. Am J Respir Crit Care Med. 1996;153(2):650‐655. [DOI] [PubMed] [Google Scholar]
  • 7. Carruthers MN, Khosroshahi A, Augustin T, Deshpande V, Stone JH. The diagnostic utility of serum IgG4 concentrations in IgG4‐related disease. Ann Rheum Dis. 2015;74(1):14‐18. [DOI] [PubMed] [Google Scholar]
  • 8. Stone JH, Zen Y, Deshpande V. IgG4‐related disease. N Engl J Med. 2012;366(6):539‐551. [DOI] [PubMed] [Google Scholar]
  • 9. Zen Y, Nakanuma Y. IgG4‐related disease: a cross‐sectional study of 114 cases. Am J Surg Pathol. 2010;34(12):1812‐1819. [DOI] [PubMed] [Google Scholar]
  • 10. Picard C, Al‐Herz W, Bousfiha A, et al. Primary immunodeficiency diseases: an update on the Classification from the International Union of Immunological Societies Expert Committee for Primary Immunodeficiency 2015. J Clin Immunol. 2015;35(8):696‐726. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11. Varghese JL, Fung AWS, Mattman A, et al. Clinical utility of serum IgG4 measurement. Clin Chim Acta. 2020;506:228‐235. [DOI] [PubMed] [Google Scholar]
  • 12. Hegade VS, Sheridan MB, Huggett MT. Diagnosis and management of IgG4‐related disease. Frontline Gastroenterol. 2019;10(3):275‐283. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13. Hao M, Liu M, Fan G, Yang X, Li J. Diagnostic value of serum IgG4 for IgG4‐related disease: a PRISMA‐compliant systematic review and meta‐analysis. Medicine. 2016;95(21):e3785. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14. Abraham M, Khosroshahi A. Diagnostic and treatment workup for IgG4‐related disease. Expert Rev Clin Immunol. 2017;13(9):867‐875. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15. Inoue D, Yoshida K, Yoneda N, et al. IgG4‐related disease: dataset of 235 consecutive patients. Medicine. 2015;94(15):e680. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16. Ma Y, Chen L, Xu Y, et al. Clinical and pathological features of patients with antineutrophil cytoplasmic antibody‐associated vasculitides concomitant with IgG4‐related disease. Int J Rheum Dis. 2019;22(12):2143‐2150. [DOI] [PubMed] [Google Scholar]
  • 17. Huijbers MG, Querol LA, Niks EH, et al. The expanding field of IgG4‐mediated neurological autoimmune disorders. Eur J Neurol. 2015;22(8):1151‐1161. [DOI] [PubMed] [Google Scholar]
  • 18. Aksu G, Genel F, Koturoglu G, Kurugol Z, Kutukculer N. Serum immunoglobulin (IgG, IgM, IgA) and IgG subclass concentrations in healthy children: a study using nephelometric technique. The. Turk J Pediatr. 2006;48(1):19‐24. [PubMed] [Google Scholar]
  • 19. Grunewald O, Lopez B, Brabant S, et al. Immunoglobulin G (IgG) and IgG subclass reference intervals in children, using Optilite(R) reagents. Clin Chem Lab Med. 2018;56:1319‐1327. [DOI] [PubMed] [Google Scholar]
  • 20. Puissant‐Lubrano B, Peres M, Apoil PA, Congy‐Jolivet N, Roubinet F, Blancher A. Immunoglobulin IgA, IgD, IgG, IgM, and IgG subclass reference values in adults. Clin Chem Lab Med. 2015;53(12):e359‐e361. [DOI] [PubMed] [Google Scholar]
  • 21. Sarnago A, Pascual RM, Moreno MJ, Laiz B, Fuster O. IgG subclasses quantitation: analytical performance of The Binding Site SPAPLUS(R) human assay and comparison with Siemens BNII(R) assay. Clin Biochem. 2018;51:85‐89. [DOI] [PubMed] [Google Scholar]
  • 22. Michaut L, Laurent N, Kentsch K, Spindeldreher S, Deckert‐Salva F. Stability of anti‐immunotherapeutic antibodies in frozen human serum samples. Bioanalysis. 2014;6(10):1395‐1407. [DOI] [PubMed] [Google Scholar]
  • 23. Sprogoe U, Yazer MH, Rasmussen MH, Antonsen B, Bistrup C, Assing K. Minimal variation in anti‐A and ‐B titers among healthy volunteers over time: Implications for the use of out‐of‐group blood components. The journal of trauma and acute care surgery. 2017;82(6S Suppl 1):S87‐s90. [DOI] [PubMed] [Google Scholar]
  • 24. Dansk Selskab for Klinisk Immunologi . Transfusionsmedicinske Standarder (Version 4.3). 2017. https://dski.dk/wp-content/uploads/2020/03/tms-5-1.pdf
  • 25. The Binding Site . SPA Plus—Assay Menu. 2020. https://www.bindingsite.com/en/our-products/clinical-chemistry/spaplus/assay-menu
  • 26. Schauer U, Stemberg F, Rieger CH, et al. IgG subclass concentrations in certified reference material 470 and reference values for children and adults determined with the binding site reagents. Clin Chem. 2003;49(11):1924‐1929. [DOI] [PubMed] [Google Scholar]
  • 27. Carballo I, Alvela L, Pérez LF, et al. Serum concentrations of IgG4 in the Spanish adult population: relationship with age, gender, and atopy. PLOS One. 2016;11(2):e0149330. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28. Santagostino A, Garbaccio G, Pistorio A, et al. An Italian national multicenter study for the definition of reference ranges for normal values of peripheral blood lymphocyte subsets in healthy adults. Haematologica. 1999;84(6):499‐504. [PubMed] [Google Scholar]
  • 29. Comans‐Bitter WM, de Groot R, van den Beemd R, et al. Immunophenotyping of blood lymphocytes in childhood. Reference values for lymphocyte subpopulations. J Pediatr. 1997;130(3):388‐393. [DOI] [PubMed] [Google Scholar]
  • 30. Aziz N, Detels R, Quint JJ, Gjertson D, Ryner T, Butch AW. Biological variation of immunological blood biomarkers in healthy individuals and quality goals for biomarker tests. BMC Immunol. 2019;20(1):33. [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Data Availability Statement

The data that support the findings of this study are available on request from the corresponding author. The data are not publicly available due to privacy or ethical restrictions.


Articles from Immunity, Inflammation and Disease are provided here courtesy of Wiley

RESOURCES